Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
8,827
-4,340
-33% -$501K 0.01% 791
2026
Q1
$1.57M Sell
13,167
-4,886
-27% -$641K 0.02% 618
2025
Q4
$2.46M Buy
18,053
+906
+5% +$130K 0.03% 448
2025
Q3
$2.53M Buy
17,147
+187
+1% +$25.9K 0.03% 442
2025
Q2
$2.19M Buy
16,960
+593
+4% +$71.8K 0.03% 438
2025
Q1
$1.96M Buy
16,367
+821
+5% +$102K 0.03% 422
2024
Q4
$1.8M Buy
15,546
+4,064
+35% +$514K 0.03% 462
2024
Q3
$1.55M Buy
+11,482
New +$1.54M 0.02% 482

Other funds holding XYL

Benjamin Edwards Inc's XYL Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Xylem (XYL) stake by 33% in Q2 2026, selling an estimated $501K and leaving 8,827 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #791.

Benjamin Edwards Inc first reported a position in XYL in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.53M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Benjamin Edwards Inc held 8,827 shares of Xylem worth $1.04M as of Q2 2026.
  • Benjamin Edwards Inc sold 4,340 Xylem shares in Q2 2026, an estimated $501K.
  • Xylem made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #791 holding.
  • Benjamin Edwards Inc first reported a position in Xylem in Q3 2024 and has held it in 8 quarters since.
  • Benjamin Edwards Inc's Xylem position peaked at $2.53M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.